Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1990 2
1991 4
1993 2
1996 1
1997 1
1998 1
1999 3
2000 1
2002 3
2003 2
2004 2
2005 2
2006 2
2007 2
2008 5
2009 2
2010 6
2011 10
2012 17
2013 11
2014 12
2015 20
2016 19
2017 17
2018 8
2019 10
2020 17
2021 27
2022 20
2023 7
2024 13
2025 14
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial.
Nash P, Kirkham B, Okada M, Rahman P, Combe B, Burmester GR, Adams DH, Kerr L, Lee C, Shuler CL, Genovese M; SPIRIT-P2 Study Group. Nash P, et al. Lancet. 2017 Jun 10;389(10086):2317-2327. doi: 10.1016/S0140-6736(17)31429-0. Epub 2017 May 24. Lancet. 2017. PMID: 28551073 Clinical Trial.
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1.
Mease PJ, van der Heijde D, Ritchlin CT, Okada M, Cuchacovich RS, Shuler CL, Lin CY, Braun DK, Lee CH, Gladman DD; SPIRIT-P1 Study Group. Mease PJ, et al. Ann Rheum Dis. 2017 Jan;76(1):79-87. doi: 10.1136/annrheumdis-2016-209709. Epub 2016 Aug 23. Ann Rheum Dis. 2017. PMID: 27553214 Free PMC article. Clinical Trial.
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.
Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Roch B, Fernández-Nebro A, Boffa MC, Hughes GR, Ingelmo M; Euro-Phospholipid Project Group. Cervera R, et al. Among authors: fernandez nebro a. Arthritis Rheum. 2002 Apr;46(4):1019-27. doi: 10.1002/art.10187. Arthritis Rheum. 2002. PMID: 11953980
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón E, Buonaiuto V, Jacobsen S, Zeher MM, Tarr T, Tincani A, Taglietti M, Theodossiades G, Nomikou E, Galeazzi M, Bellisai F, Meroni PL, Derksen RH, de Groot PG, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Fernández-Nebro A, Haro M, Amoura Z, Miyara M, Tektonidou M, Espinosa G, Bertolaccini ML, Khamashta MA; Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies). Cervera R, et al. Among authors: fernandez nebro a. Ann Rheum Dis. 2015 Jun;74(6):1011-8. doi: 10.1136/annrheumdis-2013-204838. Epub 2014 Jan 24. Ann Rheum Dis. 2015. PMID: 24464962 Free article.
Interpretable inflammation landscape of circulating immune cells.
Jiménez-Gracia L, Maspero D, Aguilar-Fernández S, Craighero F, Boulougouri M, Ruiz M, Marchese D, Caratù G, Liñares-Blanco J, Berasategi M, Ramirez Flores RO, Sanzo-Machuca A, Corraliza AM, Tran HA, Normand R, Nestor J, Hong Y, Kole T, van der Velde P, Alleblas F, Pedretti F, Aterido A, Banchero M, Soriano G, Román E, van den Berge M, Salas A, Carrascosa JM, Fernández Nebro A, Domènech E, Cañete JD, Tornero J, Gisbert JP, Choy E, Girolomoni G, Siegmund B, Julià A, Serra V, Elosua R, Tejpar S, Vidal S, Nawijn MC, Gut I, Saez-Rodriguez J, Marsal S, Villani AC, Nieto JC, Heyn H. Jiménez-Gracia L, et al. Among authors: fernandez nebro a. Nat Med. 2026 Jan 12. doi: 10.1038/s41591-025-04126-3. Online ahead of print. Nat Med. 2026. PMID: 41526507
Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus.
Rúa-Figueroa Í, Salman-Monte TC, Pego Reigosa JM, Galindo Izquierdo M, Díez Álvarez E, Fernández-Nebro A, Román Ivorra JA, Calvo Penades I, Artaraz Beobide J, Calvo Alén J. Rúa-Figueroa Í, et al. Among authors: fernandez nebro a. Reumatol Clin (Engl Ed). 2024 Jun-Jul;20(6):312-319. doi: 10.1016/j.reumae.2024.03.002. Reumatol Clin (Engl Ed). 2024. PMID: 38991825 Free article.
Gut dysbiosis is associated with difficult-to-treat rheumatoid arthritis.
Ruiz-Limón P, Mena-Vázquez N, Moreno-Indias I, Lisbona-Montañez JM, Mucientes A, Manrique-Arija S, Redondo-Rodriguez R, Cano-García L, Tinahones FJ, Fernández-Nebro A. Ruiz-Limón P, et al. Among authors: fernandez nebro a. Front Med (Lausanne). 2025 Jan 16;11:1497756. doi: 10.3389/fmed.2024.1497756. eCollection 2024. Front Med (Lausanne). 2025. PMID: 39886456 Free PMC article.
Assessing the MUC5B promoter variant in a large cohort of systemic sclerosis-associated interstitial lung disease.
Rosa-Baez C, Rangel-Pelaez C, Rodriguez-Martin I, Kerick M, Guillen-Del-Castillo A, Simeon-Aznar CP, Callejas JL, Voskuyl AE, Kreuter A, Distler O, Proudman SM, Nikpour M, Hunzelmann N, De Vries-Bouwstra JK, Herrick AL, Allanore Y, Beretta L, Mayes MD, Denton CP, Assassi S, Martin J, Acosta-Herrera M; International SSc Group; Australian Scleroderma Interest Group (ASIG). Rosa-Baez C, et al. RMD Open. 2025 Aug 12;11(3):e005754. doi: 10.1136/rmdopen-2025-005754. RMD Open. 2025. PMID: 40803819 Free PMC article.
224 results